Interpace Biosciences Inc Book/Share
What is the Book/Share of Interpace Biosciences Inc?
The Book/Share of Interpace Biosciences Inc is -21.82
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc
What does Interpace Biosciences Inc do?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Companies with book/share similar to Interpace Biosciences Inc
- Estre Ambiental has Book/Share of -23.86
- MIC Electronics has Book/Share of -23.21
- Tamilnadu Telecommunications has Book/Share of -23.05
- Diamond Power Infrastructure has Book/Share of -23.05
- Future Retail has Book/Share of -22.51
- Just has Book/Share of -22.31
- Interpace Biosciences Inc has Book/Share of -21.82
- Nq Minerals Plc Spon Ads Each R has Book/Share of -21.80
- Sotherly Hotels has Book/Share of -21.63
- Sotherly Hotels Inc has Book/Share of -21.39
- Sotherly Hotels Inc has Book/Share of -21.35
- Premier Veterinary plc has Book/Share of -21.30
- Jack In The Box has Book/Share of -21.24